FIA
XBI icon

FNY Investment Advisers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

FNY Investment Advisers’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$9K – 1017
2024
Q4 		$9K Buy
+100
New +$9.69K ﹤0.01% 498
2024
Q2 		– Sell
-20
Closed -$1 – 842
2024
Q1 		$1 Sell
20
-50
-71% -$4.64K ﹤0.01% 649
2023
Q4 		$6K Buy
+70
New +$5.2K 0.01% 346

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

FNY Investment Advisers's XBI Position: Q2 2026 in Review

FNY Investment Advisers opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 7,385 shares worth $1.17M. The stake represents 0.42% of the portfolio and ranks #59 among its holdings. This is a return to the name: FNY Investment Advisers previously reported a position in XBI as recently as Q3 2025.

FNY Investment Advisers first reported a position in XBI in Q1 2020 and has held it in 8 quarters since. The position peaked at $1.52M in Q3 2025. 561 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • FNY Investment Advisers held 7,385 shares of State Street SPDR S&P Biotech ETF worth $1.17M as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new FNY Investment Advisers position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.42% of FNY Investment Advisers's portfolio in Q2 2026, its #59 holding.
  • FNY Investment Advisers first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 8 quarters since.
  • FNY Investment Advisers's State Street SPDR S&P Biotech ETF position peaked at $1.52M in Q3 2025.
  • 561 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.